EUVIMED · CrossrefZeitschrift
Canadian Diabetes & Endocrinology Today
ISSN 2817-4097 · Catalytic Health
Neueste Artikel
Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?
Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy: A Practical Endocrine Approach to Risk Stratification and Monitoring
Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology
To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity
Androgenetic Alopecia: Pathogenesis, Evaluation, and Management
How to apply the Canadian Obesity Clinical Practice Guidelines to people with type 2 diabetes
Consideration of cannabinoids in the treatment of Diabetic Peripheral Neuropathic Pain
Type 2 diabetes remission: An overview
The use of biosimilar insulins in 2023
Addressing NAFLD as a type 2 diabetes complication using the emerging paradigms in diagnostic and management techniques
Endocrinopathies Associated with Immune Checkpoint Inhibitors
Future Role of Non-Insulin Antihyperglycemic Agents in the Management of Type 1 Diabetes Mellitus
Management of Pediatric Type 2 Diabetes
Resistance Exercise in the Context of Type 1 Diabetes
Improving Access to Endocrinologists through Provider-to-Provider eConsultations
Lipoprotein (a) in Cardiovascular Risk Assessment and Management in Diabetes Mellitus
Approach to the Management of Thyroid Eye Disease
The Role of Plant-Based Diets in the Management of Type 2 Diabetes
Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes
Case Report: A First Nation Man’s Journey with Severe Insulin Resistance Syndrome
Aging In The Face of Diabetes: Severe Hypoglycemia in Older Adults
Obstructive Sleep Apnea and Type 2 Diabetes
A Practical Approach to the Incidental Adrenal Mass
Finerenone in Diabetic Kidney Disease
Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men
The Role of Bisphosphonate Drug Holidays in the Management of Osteoporosis
Treatment of Obesity in Individuals with Type 1 Diabetes
Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus
Monogenic and Syndromic Obesity: Therapeutic Implications
Addressing Inositol Use in PCOS Management
EUVIMED